Another interesting data is that the plasma EVs contained ER-α, PR, and HER-2 (the three main prognostic markers for breast cancer), and that their levels correlated with their expression measured by immunohistochemistry in the corresponding tumors. This evidence concerns the gene ERBB2 and breast cancer.